Biotech

All Articles

Lykos will definitely talk to FDA to reconsider its choice adhering to being rejected of MDMA therapy for post-traumatic stress disorder

.Following an unsatisfactory revealing for Lykos Therapies' MDMA candidate for trauma at a current F...

AN 2 one-halfs head count, stops stage 3 test after information dissatisfy

.AN2 Therapies is actually rethinking its company in reaction to dull midphase records, swearing to ...

Merck pays for $700M for bispecific, snooping autoimmune position and also possibility to test Amgen in cancer

.Merck &amp Co. is actually paying out $700 thousand in advance to challenge Amgen in a blood stream...

Gilead pays J&ampJ $320M to go out licensing package for seladelpar

.With Gilead Sciences about to an FDA decision for its liver ailment drug seladelpar, the business h...

' All palms on deck' at Lilly as peers target obesity market

.Chief executive officer David Ricks may see the business putting together tents at basecamp respons...

Entero giving up team, vacating workplace and stopping R&ampD

.Bed Liquidators has actually switched Entero Rehabs white colored as a sheet. The creditor purchase...

Exelixis drops ADC after deciding it is actually no match for Tivdak

.Exelixis is surrendering on its own cells variable (TF)- targeting antibody-drug conjugate after co...

Relay dislikes SHP2 inhibitor after Genentech leaves behind

.Three full weeks after Roche's Genentech unit walked away from an SHP2 prevention contract, Relay R...

Stoke's Dravet syndrome med launched of predisposed medical hold

.Stoke Rehabs' Dravet syndrome medication has been actually freed from a predisposed hold, removing ...

Fierce Biotech's Gabrielle Masson shows Intense 15 at NYSE

.Fierce Biotech Affiliate Publisher Gabrielle Masson offered the 2024 class of Intense 15 champions ...